160 related articles for article (PubMed ID: 37766423)
21. Concomitant diagnosis of myeloproliferative neoplasm and non-Hodgkin's lymphoma in a patient with portal vein thrombosis.
Papageorgiou MV; Alexopoulou A; Kontopidou F; Filiotou A; Koskinas J; Pectasides D
Anticancer Res; 2011 Apr; 31(4):1467-9. PubMed ID: 21508404
[TBL] [Abstract][Full Text] [Related]
22. Surgically restoring portal blood flow to the liver in children with primary extrahepatic portal vein thrombosis improves fluid neurocognitive ability.
Mack CL; Zelko FA; Lokar J; Superina R; Alonso EM; Blei AT; Whitington PF
Pediatrics; 2006 Mar; 117(3):e405-12. PubMed ID: 16481447
[TBL] [Abstract][Full Text] [Related]
23. [Essential thrombocythemia. Contribution of the V617F JAK2 mutation to the pathophysiology, diagnosis and outcome].
Brière J
Bull Acad Natl Med; 2007 Mar; 191(3):535-48. PubMed ID: 18072652
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular carcinoma presenting as an incidental isolated malignant portal vein thrombosis.
Poddar N; Avezbakiyev B; He Z; Jiang M; Gohari A; Wang JC
J Gastrointest Cancer; 2012 Sep; 43(3):486-9. PubMed ID: 21190093
[TBL] [Abstract][Full Text] [Related]
25. Essential thrombocythemia: a review of diagnostic and pathologic features.
Sanchez S; Ewton A
Arch Pathol Lab Med; 2006 Aug; 130(8):1144-50. PubMed ID: 16879015
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis.
De Stefano V; Teofili L; Leone G; Michiels JJ
Semin Thromb Hemost; 1997; 23(5):411-8. PubMed ID: 9387199
[TBL] [Abstract][Full Text] [Related]
27. Undiagnosed myeloproliferative disease in cases of intra-abdominal thrombosis: the utility of the JAK2 617F mutation.
P'ng S; Carnley B; Baker R; Kontorinis N; Cheng W
Clin Gastroenterol Hepatol; 2008 Apr; 6(4):472-5. PubMed ID: 18328792
[TBL] [Abstract][Full Text] [Related]
28. Aberrant Platelet Aggregation as Initial Presentation of Essential Thrombocythemia: Failure of Entero-Coated Aspirin to Reduce Platelet Hyperactivation.
Morotti A; Barale C; Sornatale M; Giugliano E; Muccio VE; Frascaroli C; Pautasso M; Fornari A; Russo I
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203347
[TBL] [Abstract][Full Text] [Related]
29. Gastroesophageal varices in a patient presenting with essential thrombocythemia: A case report.
Wang JB; Gao Y; Liu JW; Dai MG; Yang SW; Ye B
World J Clin Cases; 2021 Mar; 9(8):1871-1876. PubMed ID: 33748236
[TBL] [Abstract][Full Text] [Related]
30. Primary Myelofibrosis in the Prefibrotic Stage Presenting as Portal, Splenic, and Superior Mesenteric Vein Thrombosis: A Case Report and Review of the Literature.
Dias E; Liberal R; Costa-Moreira P; Príncipe F; Fonseca E; Macedo G
GE Port J Gastroenterol; 2022 Mar; 29(2):125-131. PubMed ID: 35497670
[TBL] [Abstract][Full Text] [Related]
31. A case of ischemic stroke with hemorrhagic transformation associated with essential thrombocythemia and JAK-2 V617F mutation.
Yan R; Mi D; Qiu X; Li Z
BMC Neurol; 2022 Nov; 22(1):437. PubMed ID: 36397023
[TBL] [Abstract][Full Text] [Related]
32. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
Iványi JL; Marton E; Plander M
Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
[TBL] [Abstract][Full Text] [Related]
33. [Superior mesenteric and portal vein thrombosis in a polycythemia vera patient with JAK2 mutation].
Araki N; Takimoto R; Chiba H; Araki H; Sato T; Iyama S; Hirakawa M; Ono K; Kawano Y; Takada K; Miyanishi K; Kobune M; Matsunaga T; Kato J; Nakamura T; Niitsu Y
Rinsho Ketsueki; 2007 Jul; 48(7):554-8. PubMed ID: 17695304
[TBL] [Abstract][Full Text] [Related]
34. Treatment of gastric varices with partial splenic embolization in a patient with portal vein thrombosis and a myeloproliferative disorder.
Gianotti R; Charles H; Hymes K; Chandarana H; Sigal S
World J Gastroenterol; 2014 Oct; 20(39):14495-9. PubMed ID: 25339837
[TBL] [Abstract][Full Text] [Related]
35. [Splenoportal thrombosis: form of presentation of essential thrombocythemia].
Jiménez Sáenz JM; Gómez Berne J; Pérez Layo A; Sanjuán Portugal F; Hermida Lazcano I
An Med Interna; 1998 Nov; 15(11):594-6. PubMed ID: 9882858
[TBL] [Abstract][Full Text] [Related]
36. [Vascular complications of essential thrombocythemia].
Bellucci S
Bull Acad Natl Med; 2007 Mar; 191(3):519-30; discussion 530-3. PubMed ID: 18072651
[TBL] [Abstract][Full Text] [Related]
37. [Portal vein thrombosis associated with essential thrombocytosis. Clinical cases and review of the literature].
Carvajal S; Zapata R; Bertín P; Miquel JF
Rev Med Chil; 1996 Mar; 124(3):353-8. PubMed ID: 9008949
[TBL] [Abstract][Full Text] [Related]
38. Acute upper gastrointestinal bleeding due to portal hypertension in a patient with primary myelofibrosis: A case report.
Chen Y; Kong BB; Yin H; Liu H; Wu S; Xu T
World J Clin Cases; 2024 May; 12(15):2621-2626. PubMed ID: 38817215
[TBL] [Abstract][Full Text] [Related]
39. Portal vein thrombosis as the first sign of a primary myeloproliferative disorder: diagnostic interest of the V617F JAK-2 mutation. A report of 2 cases.
de Suray N; Pranger D; Brenard R
Acta Gastroenterol Belg; 2008; 71(1):39-41. PubMed ID: 18396750
[TBL] [Abstract][Full Text] [Related]
40. Annual Clinical Updates in Hematological Malignancies: a continuing medical education series: polycythemia vera and essential thrombocythemia: 2011 update on diagnosis, risk-stratification, and management.
Tefferi A
Am J Hematol; 2011 Mar; 86(3):292-301. PubMed ID: 21351120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
